Saniona to participate in multiple upcoming investor conferences
March 01 2022 - 1:00AM
Saniona to participate in multiple upcoming investor conferences
PRESS RELEASE
March 1,
2022
Saniona (OMX: SANION), a
clinical-stage biopharmaceutical
company focused on rare diseases, today announced
that it will present at multiple upcoming investor
conferences. Details are as follows:
Redeye Investor Forum – Göteborg, SwedenDate/Time: 10 March
2022, 1:00 p.m. ET / 19.00 CETPresenter: Trista Morrison, Chief
Communications OfficerWebcast Link:
https://www.redeye.se/events/825158/investor-forum-goteborg
Aktiespararna Stockholm Share Day – Stockholm, SwedenDate/Time:
14 March 2022, 11:00 a.m. EDT / 16.00 CETPresenter: Trista
Morrison, Chief Communications OfficerWebcast Link:
https://www.aktiespararna.se/aktiviteter/aktiedagen-stockholm-14-15-mars-2022
Oppenheimer’s 32nd Annual Healthcare Conference –
VirtualDate/Time: 16 March 2022, 8:00 a.m. EDT / 13.00
CETPresenter: Rami Levin, President and CEOWebcast Link:
https://wsw.com/webcast/oppenheimer20/register.aspx?conf=oppenheimer20&page=sanion.st&url=https://wsw.com/webcast/oppenheimer20/sanion.st/3832038
ØU Life Science Investor Conference – Copenhagen,
DenmarkDate/Time: 16 March 2022, 11:05 a.m. EDT / 16.05
CETPresenter: Jørgen Drejer, Founder and Chief Scientific Officer
(in Danish)Webcast Link: no live webcast; recording will be
available on Saniona website after event
Aktieinfo Life Science Conference – Copenhagen,
DenmarkDate/Time: 4 April, 2022, 2:35 p.m. EDT / 20.35
CESTPresenter: Jørgen Drejer, Founder and Chief Scientific Officer
(in Danish)Website link:
https://www.aktieinfo.net/investorarrangementer/. No live webcast;
recording will be available on Saniona website after event
Aktiespararna Women’s Night – Göteborg, SwedenDate/Time: 25
April 2022Presenter: Trista Morrison, Chief Communications
OfficerWebsite Link: Not yet available
Redeye Orphan Drugs SeminarDate/Time: 27 April 2022Presenter:
Trista Morrison, Chief Communications OfficerWebsite Link:
https://www.redeye.se/events/825140/redeye-theme-orphan-drugs
As presenting times and live webcast links become available,
they will be shared on the Saniona website in the Events &
Presentations
section: https://ir.saniona.com/events-and-presentations. Live
webcasts will be available at the links provided. Subsequently, the
recorded webcast events will be archived for approximately 90 days
on Saniona’s website.
For more information, please contact Trista
Morrison, Chief Communications Officer, Saniona. Office: + 1 (781)
810-9227. Email: trista.morrison@saniona.com
The information was submitted for publication, through the
agency of the contact person set out above, at 8.00 CET on 1 March
2022.
About Saniona Saniona is a clinical-stage
biopharmaceutical company focused on discovering, developing and
commercializing innovative therapies for patients suffering from
rare diseases for which there are a lack of available treatment
options. The company’s lead product candidate, Tesomet™, is in
mid-stage clinical trials for hypothalamic obesity and Prader-Willi
syndrome, serious rare disorders characterized by severe weight
gain, disturbances of metabolic functions and uncontrollable
hunger. Saniona has developed a proprietary ion channel drug
discovery engine anchored by IONBASE™, a database of more than
130,000 compounds, of which more than 20,000 are Saniona’s
proprietary ion channel modulators. Through its ion channel
expertise, Saniona is advancing two wholly-owned ion channel
modulators, SAN711 and SAN903. SAN711 is in a Phase 1 clinical
trial and may be applicable in the treatment of rare neuropathic
disorders, and SAN903 is in preclinical development for rare
inflammatory, fibrotic and hematological disorders. Led by an
experienced scientific and operational team, Saniona has an
established research organization in the Copenhagen area, Denmark,
and a corporate office in the Boston, Massachusetts area, U.S. The
company’s shares are listed on Nasdaq Stockholm Small Cap (OMX:
SANION). Read more at http://www.saniona.com.
- EventUpdate Mar-Apr22 03.01.22
Saniona Ab (LSE:0RQJ)
Historical Stock Chart
From Jan 2025 to Feb 2025
Saniona Ab (LSE:0RQJ)
Historical Stock Chart
From Feb 2024 to Feb 2025
